News Digest 24.06.2024 — 26.06.2024
Regulators
The State Duma adopted the bill on state regulation of methanol turnover in the first reading
The State Duma adopted the bill on state regulation of methanol and methanol-containing liquids turnover in Russia in the first reading. It proposes to create a register of organizations and individual entrepreneurs that carry out the turnover of such products. The document also prohibits the retail sale of methanol and regulates the requirements for the turnover, transportation, storage and disposal of methanol.
The Ministry of Finance has prepared amendments to the draft law on excise tax on alcohol for the second reading
The Ministry of Finance has developed a draft amendment to the draft federal law No. 639663-8 "On Amendments to Parts One and Two of the Tax Code of the Russian Federation and Certain Legislative Acts of the Russian Federation" (available to FV). It was approved by the State Duma on June 20 in the first reading.
With regard to excise taxes on the pharmaceutical substance of ethyl alcohol, medicinal products and (or) medical devices that do not contain ethyl alcohol or the volume fraction of ethyl alcohol is no more than 20% are considered to be provided for by the relevant lists of pharmaceutical products, without the need for their additional indication in such lists.
The draft amendments also provide for an increase in the deadline for paying the calculated excise tax upon receipt (receipt) of a pharmaceutical substance to the 28th day of the ninth month following the tax period in which the relevant transactions were made.
Market news
MIP-Test brought Chinese SinoVision tomographs to the Russian market
The Russian distributor MIP-Test (close to NPF MIP-Nano, which developed a domestic high-field magnetic resonance tomograph) received a registration certificate for Insitum computed tomographs manufactured by the Chinese vendor SinoVision. Previously, the devices were already supplied to Russia in the Adani version localized in the Republic of Belarus, which were validated in the summer of 2022 and autumn of 2023, as well as as part of the mobile complex of ZAO NPO Medkar, which received a dossier for a mobile complex with a tomograph in November 2023.
Roszdravnadzor issued a registration certificate for the 32-slice version of InsitumCT 338, as well as 64-slice tomographs AlphaCT 328 Plus and AlphaCT 358 Plus. The circulation of the devices is permitted from June 21, 2024. The latter have already been supplied to Russia, but as tomographs for veterinary clinics.
This is not the first appearance of the Sinovision Technologies tomograph on the Russian market, but for the first time it has been launched by the company directly. Thus, in 2022 and 2023, the Russian representative office of the Belarusian manufacturer of medical equipment Adani registered in Russia a 32- and 128-slice Ventum computed tomograph, created on the basis of a localized version of the Chinese Insitum series tomographs from Sinovision Technologies. In November 2023, the Moscow Region-based NPO Medkar CJSC received a registration certificate for a mobile medical complex (PMC) for computed tomography with a localized version of the device under the X-RAYNIKA Mobile brand. As follows from the dossier, the complex is allowed to use domestic units or original ones - manufactured by the Chinese Sinovision Technologies.
Chelyabinsk Oncology Center failed to sue for 1.33 billion rubles for the failure to deliver a tomograph
The Arbitration Court of the Chelyabinsk Region ruled to collect 13.3 million rubles from the local company Anlamed for the untimely delivery of a tomograph to the Regional Oncology Center No. 2 in Magnitogorsk.
The medical institution will receive a hundred times less than it claimed in the lawsuit: the oncology center intended to sue for 1.33 billion rubles. The case concerns a penalty for the delivery of medical equipment worth 93.4 million rubles, which was almost five months late.
The defendant called the oncology center's demands excessive and explained the delay by the sanctions imposed after the start of the SVO and the violation of logistical connections. The court found that the hospital's demands were excessive, and therefore partially satisfied the claim.
The management of the oncology center filed a statement of claim with the court in July 2023. In the claim, the medical institution asked to recover a penalty from the Chelyabinsk company under the contract for the supply of a tomograph for the period from December 20, 2022 to May 11, 2023. The contract with Anlamed LLC was concluded on June 22, 2022 at a price of 93.4 million rubles. According to its terms, the company was to deliver a Vantage Elan tomograph from Japanese Canon Medical Systems within 180 days from the date of the contract. But this clause of the contract was not fulfilled. “In accordance with paragraph 6.3 of the contract, for violation of the terms of delivery of goods, the supplier pays the customer a penalty in the amount of 10% of the cost of the goods actually not delivered for each day of delay,” the case materials state. As a result, over 143 days, the oncology center calculated a penalty of 1.33 billion rubles.
The company admitted to violating the terms of the supply agreement, but did not agree with the length of the delay and the amount of the penalty. Anlamed was ready to pay only 489.5 thousand rubles for 18 days of delay.
During the consideration of the case, the court considered that the beginning of the SVO, as well as the introduction of economic and political sanctions against Russia, cannot be a circumstance that automatically excludes the defendant's guilt in improper performance of the contract. The company did not provide any documentary evidence that the management took any measures to deliver medical equipment to the oncology center on time.
Other
Moscow scientists have developed the first phantom in Russia for fetal MRI
Scientists from the Scientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Department of Health (SPCC DIT DZM) have developed the first fetal phantom in Russia for setting up magnetic resonance imaging technology for pregnant women. With the new medical device, which imitates organs, tissues and body parts of a human, the time of the study will be reduced, which will ensure its widespread use as an additional diagnostic method for pregnant women, the press service of the Center reported.
Currently, in order to set up an MRI scanning protocol, doctors and X-ray technicians often resort to the help of pregnant patients - volunteers. The procedure does not harm the mother and fetus, but the woman has to spend a long time in the scanner in a position that is not very comfortable. In addition, spontaneous movements of the fetus and the mother's breathing cause interference in the images obtained and significantly reduce the information content of the study.
As explained by the chief freelance specialist in radiation and instrumental diagnostics of the Department of Health of the Ministry of Health, director of the Scientific and Practical Center of Diagnostics and Technology Yuri Vasiliev, the task was to create a phantom that would give the same picture on MRI images as when scanning a pregnant woman. Materials with a signal intensity identical to the internal organs of the fetus were selected experimentally - mainly gel compositions. In this way, an imitation of the brain, muscle tissue, lungs, liver, stomach and bladder of the fetus was obtained. Then, using volumetric printing, a case was created that repeated the anatomy of the uterus and fetus at the 21st week of pregnancy, and filled it with these compositions.
The developers plan to add the ability to move to the phantom, since the fetus is not always in a motionless state during the study. The medical device can be used to train doctors and X-ray technicians, evaluate and test equipment standards in everyday clinical practice, and develop new scanning protocols.
Startup Neiry raised 300 million rubles to produce headphones with vagus nerve stimulation
Russian developer of IT products and platform solutions based on neurotechnology Neiry attracted investments in the amount of 300 million rubles from the venture fund Voskhod (part of the Interros group of billionaire Vladimir Potanin) and a group of private investors to refine and commercialize products, including in-ear headphones with vagus nerve stimulation inside the ear canal Neiry Buds+.
According to Voskhod, the fund received a minority stake in the company.
The funding, as specified by Neiry, will allow for the refinement of the Neiry Buds+ earbuds with vagus nerve stimulation inside the ear canal. In April 2024, the company presented a prototype of the device, developed jointly with the Bekhterev National Medical Research Center of Psychiatry and Neurology. The developer claims that the headphones are capable of normalizing the functioning of the parasympathetic nervous system. This should help in the fight against depression, epilepsy, insomnia and migraines, and will also reduce anxiety and stress.
News
